These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 26202258)
21. Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents. Werling D; Reglodi D; Banks WA; Salameh TS; Kovacs K; Kvarik T; Vaczy A; Kovacs L; Mayer F; Danyadi B; Lokos E; Tamas A; Toth G; Biro Z; Atlasz T Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6683-6691. PubMed ID: 27936470 [TBL] [Abstract][Full Text] [Related]
22. Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathway. Li C; Chen P; Zhang J; Zhang L; Huang X; Yao Y; Che X; Fan X; Ge S; Wang Z Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4964-70. PubMed ID: 23847321 [TBL] [Abstract][Full Text] [Related]
23. VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina. Teuchner B; Dimmer A; Humpel C; Amberger A; Fischer-Colbrie R; Nemeth J; Waschek JA; Kieselbach G; Kralinger M; Schmid E; Bechrakis N; Troger J Acta Ophthalmol; 2011 Nov; 89(7):670-5. PubMed ID: 20064115 [TBL] [Abstract][Full Text] [Related]
24. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo. Jiang S; Chen X Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154 [TBL] [Abstract][Full Text] [Related]
25. PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy. D'Amico AG; Maugeri G; Musumeci G; Reglodi D; D'Agata V J Mol Neurosci; 2021 Aug; 71(8):1525-1535. PubMed ID: 33403597 [TBL] [Abstract][Full Text] [Related]
27. A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats. Jian W; Yu S; Tang M; Duan H; Huang J J Ethnopharmacol; 2016 Apr; 182():50-6. PubMed ID: 26692279 [TBL] [Abstract][Full Text] [Related]
28. PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype. Wada Y; Nakamachi T; Endo K; Seki T; Ohtaki H; Tsuchikawa D; Hori M; Tsuchida M; Yoshikawa A; Matkovits A; Kagami N; Imai N; Fujisaka S; Usui I; Tobe K; Koide R; Takahashi H; Shioda S J Mol Neurosci; 2013 Oct; 51(2):493-502. PubMed ID: 23720065 [TBL] [Abstract][Full Text] [Related]
29. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055 [TBL] [Abstract][Full Text] [Related]
30. PACAP application improves functional outcome of chronic retinal ischemic injury in rats-evidence from electroretinographic measurements. Danyadi B; Szabadfi K; Reglodi D; Mihalik A; Danyadi T; Kovacs Z; Batai I; Tamas A; Kiss P; Toth G; Gabriel R J Mol Neurosci; 2014 Nov; 54(3):293-9. PubMed ID: 24723665 [TBL] [Abstract][Full Text] [Related]
31. [Expression of stromal cell-derived factor 1 is increased in the retina of experimental diabetic rats]. Yuan YZ; Yuan F; Li L; Wang Y; Tong BY Zhonghua Yan Ke Za Zhi; 2007 Oct; 43(10):912-6. PubMed ID: 18201529 [TBL] [Abstract][Full Text] [Related]
32. Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion. Szabo A; Danyadi B; Bognar E; Szabadfi K; Fabian E; Kiss P; Mester L; Manavalan S; Atlasz T; Gabriel R; Toth G; Tamas A; Reglodi D; Kovacs K Neurosci Lett; 2012 Aug; 523(2):93-8. PubMed ID: 22750211 [TBL] [Abstract][Full Text] [Related]
33. The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration. Vaczy A; Reglodi D; Somoskeoy T; Kovacs K; Lokos E; Szabo E; Tamas A; Atlasz T J Mol Neurosci; 2016 Oct; 60(2):186-94. PubMed ID: 27566170 [TBL] [Abstract][Full Text] [Related]
35. PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study. Varga B; Szabadfi K; Kiss P; Fabian E; Tamas A; Griecs M; Gabriel R; Reglodi D; Kemeny-Beke A; Pamer Z; Biro Z; Tosaki A; Atlasz T; Juhasz B J Mol Neurosci; 2011 Jan; 43(1):44-50. PubMed ID: 20567936 [TBL] [Abstract][Full Text] [Related]
36. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. García-Ramírez M; Hernández C; Simó R Diabetes Care; 2008 Jun; 31(6):1189-94. PubMed ID: 18332162 [TBL] [Abstract][Full Text] [Related]
38. PACAP and VIP regulate hypoxia-inducible factors in neuroblastoma cells exposed to hypoxia. Maugeri G; D'Amico AG; Rasà DM; Saccone S; Federico C; Cavallaro S; D'Agata V Neuropeptides; 2018 Jun; 69():84-91. PubMed ID: 29699729 [TBL] [Abstract][Full Text] [Related]
39. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats. Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551 [TBL] [Abstract][Full Text] [Related]
40. A novel specific application of pyruvate protects the mouse retina against white light damage: differential stabilization of HIF-1α and HIF-2α. Ren H; Liu NY; Song XF; Ma YS; Zhai XY Invest Ophthalmol Vis Sci; 2011 May; 52(6):3112-8. PubMed ID: 21228376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]